Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-38054226

RESUMO

Glioma cell cultures are used in basic researches of tumor processes, personalized medicine for selecting treatment regimens depending on individual characteristics of patients and pharmacology for assessing the effectiveness of chemotherapy. Suppression of glioma culture growth without reduction of malignancy grade is common. Drug cancellation may be followed by substitution of precursor cells by more malignant clones. Therefore, analysis of culture cell malignancy grade is important. In the future, intraoperative analysis of glioma cell malignancy grade can be used to select individual therapy. OBJECTIVE: We analyzed the relationship between expression of marker genes TUBB3, CD133, CDK4, CDK6, CIRBP, DR4, DR5, EGFR, FGFR, FSHR, GDNF, GFAP, L1CAM, LEF1, MAP2, MDM2, MELK, NANOG, NOTCH2, OCT4, OLIG2, PDGFRA, PDGFA, PDGFB and SOX2 and glioma cell malignancy grade, as well as created appropriate prognostic model. MATERIAL AND METHODS: We analyzed expression of 25 marker genes in 22 samples of human glioma cultures using quantitative real-time PCR. Statistical analysis was performed using the IBM SPSS Statistics 26.0 software. We used the Kolmogorov-Smirnov and Shapiro-Wilk tests to assess distribution normality. Nonparametric Jonckheere-Terpstra and Spearman tests were applied. RESULTS: We obtained a prognostic model for assessing the grade III and IV glioma cell malignancy based on expression of marker genes MDM2, MELK, SOX2, CDK4, DR5 and OCT4. Predictive accuracy was 83% (Akaike information criterion -55.125).


Assuntos
Glioma , Humanos , Prognóstico , Glioma/genética , Receptor Notch2/genética , Receptor Notch2/metabolismo , Expressão Gênica , Proteínas Proto-Oncogênicas c-mdm2/genética , Proteínas Proto-Oncogênicas c-mdm2/metabolismo , Proteínas Proto-Oncogênicas c-mdm2/uso terapêutico , Proteínas Serina-Treonina Quinases/genética , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Serina-Treonina Quinases/uso terapêutico , Quinase 4 Dependente de Ciclina/genética , Quinase 4 Dependente de Ciclina/metabolismo , Quinase 4 Dependente de Ciclina/uso terapêutico , Proteínas de Ligação a RNA/genética , Proteínas de Ligação a RNA/uso terapêutico , Fatores de Transcrição SOXB1/genética , Fatores de Transcrição SOXB1/metabolismo
2.
Bull Exp Biol Med ; 174(4): 518-522, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36899203

RESUMO

We compared the expression of the main glioblastoma oncogenes during therapy with doxorubicin (Dox) and Dox in nanoparticles based on a copolymer of lactic and glycolic acids (Dox-PLGA) at a delayed start of treatment. Late initiation of Dox-PLGA therapy of glioblastoma showed an increase in the expression of multiple drug resistance genes, such as Abcb1b and Mgmt, and a decrease in Sox2 expression. Increased expression of other oncogenes (Melk, Wnt3, Gdnf, and Pdgfra) were observed during both Dox and Dox-PLGA therapy. These changes indicate increased tumor aggressiveness and its resistance to cytostatics at the late start of therapy.


Assuntos
Doxorrubicina , Glioblastoma , Nanopartículas , Animais , Ratos , Linhagem Celular Tumoral , Doxorrubicina/uso terapêutico , Portadores de Fármacos , Glioblastoma/tratamento farmacológico , Glioblastoma/genética , Nanopartículas/uso terapêutico , Oncogenes , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Modelos Animais de Doenças , Testes Farmacogenômicos
3.
Artigo em Russo | MEDLINE | ID: mdl-35170278

RESUMO

BACKGROUND: Doxorubicin is a well-known antitumor drug that is not employed for chemotherapy of brain tumors. Indeed, doxorubicin does not penetrate across the blood-brain barrier in therapeutic concentrations. OBJECTIVE: To study the antitumor effect of doxorubicin combined with nitrosorbide on intracranial experimental glioblastoma 101/8 in rats. MATERIAL AND METHODS: Male Wistar rats (n=86) with intracranial implanted glioblastoma 101/8 received doxorubicin (i.v. 1.5 mg/kg thrice) alone or in combination with nitrosorbide (i.v or orally, 0.5 mg/kg thrice) in 2, 5 and 8 days after implantation. Efficacy was assessed considering survival and brain tumor volume in 14 days after tumor implantation. RESULTS: Combination of doxorubicin and nitrosorbide significantly increased survival (57% and 155%, respectively) and slowed down tumor growth (16±12 and 8±6 mm3, respectively) compared to doxorubicin alone. Effectiveness of nitrosorbide alone was trivial. CONCLUSION: Nitric oxide donor nitrosorbide considerably potentiated the antitumor effect of doxorubicin against intracranial 101/8 glioblastoma in rats.


Assuntos
Neoplasias Encefálicas , Glioblastoma , Animais , Neoplasias Encefálicas/tratamento farmacológico , Doxorrubicina/farmacologia , Glioblastoma/tratamento farmacológico , Dinitrato de Isossorbida/farmacologia , Masculino , Doadores de Óxido Nítrico/farmacologia , Ratos , Ratos Wistar
4.
Izv Akad Nauk Ser Biol ; (4): 341-347, 2016 Jul.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-30251786

RESUMO

Transgenic clones of mouse embryonic stem cells of the RI line were -received by transfection of plasmid linear vectors. The changes in the transgene structure during its integration into the genome of the target cells were investigated. Displacements were found on the flanks of the integrated transgene. It was found that multicopy tandem structures are formed in head- -tail orientation at the transgene integration. It was noted that the number of copies of the integrated transgenes varies considerably, but the introduction of DNA fragments from the nuclear shells into the flanks of the transgene normalizes the number of its copies.


Assuntos
Dosagem de Genes , Células-Tronco Embrionárias Murinas/metabolismo , Transfecção , Transgenes , Animais , Camundongos , Camundongos Transgênicos , Células-Tronco Embrionárias Murinas/citologia
5.
Ontogenez ; 39(3): 208-11, 2008.
Artigo em Russo | MEDLINE | ID: mdl-18634333

RESUMO

The survival of transgenic mouse embryos was studied as a function of the transgene structure. The data obtained indicate that the introduction of a chromosomal DNA fragment providing for the anchoring of interphase chromosomes on the nuclear envelope increases the efficiency of transgenesis in mice threefold due to their increased viability.


Assuntos
Cromossomos de Mamíferos/genética , Embrião de Mamíferos/metabolismo , Técnicas de Transferência de Genes , Interfase/fisiologia , Membrana Nuclear/metabolismo , Transgenes/fisiologia , Animais , Cromossomos de Mamíferos/metabolismo , Embrião de Mamíferos/citologia , Feminino , Masculino , Camundongos , Camundongos Endogâmicos CBA , Camundongos Transgênicos , Membrana Nuclear/genética
6.
Genetika ; 35(2): 266-70, 1999 Feb.
Artigo em Russo | MEDLINE | ID: mdl-10495943

RESUMO

Six DNA fragments of interphase chromosomes isolated from nuclear envelopes of murine hepatocytes were cloned and sequenced. Analysis of their structural-functional organization suggests that these fragments are highly specified protein-nonencoding fractions of a eukaryotic genome. In the evolutionary process, they appear already in archaebacteria and may be "ancestral" for DNA sequences involved in structuring chromosomal domains (rosette-like structures) of tissue-specific genes. In their composition, these fragments have nucleotide sequences homologous to the repeats of the SINE and LINE families and to the satellite DNA of murine centromeres.


Assuntos
Cromossomos/genética , DNA/genética , Membrana Nuclear/genética , Análise de Sequência de DNA , Animais , Sequência de Bases , Cromossomos/ultraestrutura , Interfase , Camundongos , Dados de Sequência Molecular , Membrana Nuclear/ultraestrutura
8.
Biull Eksp Biol Med ; 98(10): 434-6, 1984 Oct.
Artigo em Russo | MEDLINE | ID: mdl-6388658

RESUMO

A single subcutaneous injection of a long-acting immobilized insulin preparation activated biosynthetic events in the liver and skin of the burnt animals and slowed down tissue degradation as evidenced by creatine excretion. This insulin preparation can be successfully used for the treatment of burnt patients in order to stimulate metabolism and maintain normoglycemia.


Assuntos
Queimaduras/tratamento farmacológico , Insulina/uso terapêutico , Animais , Queimaduras/metabolismo , Colinesterases/sangue , Creatina/urina , Preparações de Ação Retardada , Avaliação Pré-Clínica de Medicamentos , Fígado/metabolismo , Masculino , Ratos , Pele/metabolismo , Suspensões
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA